Quantitative Investment Management LLC Buys Shares of 31,059 Ventas, Inc. $VTR

Quantitative Investment Management LLC bought a new position in shares of Ventas, Inc. (NYSE:VTR) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 31,059 shares of the real estate investment trust’s stock, valued at approximately $2,173,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Cloud Capital Management LLC bought a new stake in shares of Ventas during the 3rd quarter valued at approximately $25,000. True Wealth Design LLC lifted its stake in Ventas by 1,557.7% in the 3rd quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after purchasing an additional 405 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its stake in Ventas by 65.5% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 180 shares during the last quarter. ORG Partners LLC boosted its position in Ventas by 76.1% in the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock valued at $32,000 after buying an additional 197 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC acquired a new stake in Ventas in the second quarter valued at approximately $35,000. Institutional investors own 94.18% of the company’s stock.

Ventas Trading Up 0.4%

Shares of NYSE VTR opened at $86.14 on Friday. The firm has a 50 day moving average price of $81.27 and a two-hundred day moving average price of $76.19. The stock has a market cap of $40.91 billion, a P/E ratio of 159.51, a price-to-earnings-growth ratio of 2.09 and a beta of 0.73. Ventas, Inc. has a 52-week low of $60.15 and a 52-week high of $87.87. The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.67 and a current ratio of 0.67.

Ventas (NYSE:VTR) last issued its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). Ventas had a return on equity of 2.09% and a net margin of 4.31%.The business had revenue of ($1,229.71) million for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter last year, the firm posted $0.81 EPS. Ventas’s revenue for the quarter was up 21.7% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. As a group, equities analysts forecast that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, April 16th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a boost from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio (DPR) is presently 355.56%.

Insider Buying and Selling at Ventas

In other Ventas news, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.25, for a total value of $2,312,092.50. Following the sale, the chief financial officer owned 138,434 shares in the company, valued at approximately $10,694,026.50. The trade was a 17.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Carey S. Roberts sold 35,532 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the sale, the executive vice president directly owned 72,755 shares of the company’s stock, valued at approximately $6,184,175. The trade was a 32.81% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 86,106 shares of company stock worth $6,931,397. Insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

VTR has been the topic of a number of research reports. The Goldman Sachs Group reaffirmed a “buy” rating and set a $100.00 target price on shares of Ventas in a research note on Monday, February 9th. KeyCorp raised their price objective on Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, February 10th. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Royal Bank Of Canada upped their target price on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a report on Tuesday, February 10th. Finally, Morgan Stanley set a $90.00 target price on Ventas in a research report on Friday, February 13th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $89.00.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.